Extensive enrichment of N-glycolylneuraminic acid in extracellular sialoglycoproteins abundantly synthesized and secreted by human cancer cells

Glycobiology

Volumn 20, Issue 6, 2010, Pages 752-762

  Inoue, Sadako ^a   Sato, Chihiro ^a   Kitajima, Ken ^a  

^a NAGOYA UNIVERSITY   (Japan)

Author keywords

Cancer sialic acid; Human extracellular Neu5Gc rich glycoprotein; Human Neu5Gc; Neu5Gc accumulation

Indexed keywords

GLYCOCONJUGATE; N GLYCOLOYLNEURAMINIC ACID; SIALIC ACID; SIALOGLYCOPROTEIN; TRYPSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; ENRICHMENT CULTURE; FLUOROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYDROXYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; SUPERNATANT;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EXTRACELLULAR SPACE; HUMANS; MICE; NEOPLASMS; NEURAMINIC ACIDS; SIALOGLYCOPROTEINS; TRYPSIN; TUMOR CELLS, CULTURED;

MAMMALIA; SIA;

EID: 77952798093     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwq030     Document Type: Article

References (40)

1. Angata T, Nakata D, Matsuda T, Kitajima K. 1999. Elevated expression of free deaminoneuraminic acid in mammalian cells cultured in mannose-rich media. Biochem Biophys Res Commun. 261:326-331.
2. Bardor M, Nguyen DH, Diaz S, Varki A. 2005. Mechanism of uptake and incorporation of the non-human sialic acid N-glycolylneuraminic acid into human cells. J Biol Chem. 280:4228-4237.
3. Bhavanandan VP. 1991. Cancer-associated mucins and mucin-type glycoproteins. Glycobiology. 1:493-503.
4. Burchell JM, Poulsom R, Hanby A, Whitehouse C, Cooper L, Clausen H, Miles D, Taylor-Papadimitriou J. 1999. An (2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas. Glycobiology. 9:1307-1311.
5. Burchell JM, Mungul A, Taylor-Papadimitriou J. 2001. O-Linked glycosylation in the mammary gland: Changes that occur during malignancy. J Mammary Gland Biol Neoplasia. 6:355-364.
6. Carraway KL, Hull SR. 1991. Cell surface mucin-type glycoproteins and mucin-like domains. Glycobiology. 1:131-138.
7. Dalziel M, Whitehouse C, McFarlane I, Brockhausen I, Gschmeissner S, Schwientek T, Clausen H, Burchell JM, Taylor-Papadimitriou J. 2001. The relative activities of the C2GnT1 and ST3Gal-I glycosyltransferases determine O-glycan structure and expression of a tumor-associated epitope on MUC1. J Biol Chem. 276:11007-11015.
8. Devine PL, ClarkBA, Birrell GW, Layton GT, Ward BG, Alewood PF, McKenzie IFC. 1991. The breast tumor-associated epitope defined by monoclonal antibody 3E1.2 is an O-linked mucin carbohydrate containing N-glycolylneuraminic acid. Cancer Res. 51:5826-5836.
9. Dong Y, Walsh MD, Cummings MC, Wright RG, Khoo SK, Parsons PG, McGuckin MA. 1997. Expression of MUC1 and MUC2 mucins in epithelial ovarian tumours. J Pathol. 183:311-317.
10. Engelmann K, Kinlough CL, Muller S, Razawi H, Baldus SE, Hughey RP, Hanisch F-G. 2005. Transmembrane and secreted MUC1 probes show trafficking-dependent changes in O-glycan core profiles. Glycobiology. 15:1111-1124.
11. Feng H, Ghazizadeh M, Konishi H, Araki T. 2002. Expression of MUC1 and MUC2 mucin gene products in human ovarian carcinomas. Jpn J Clin Oncol. 32:525-529.
12. Gendler SJ, Burchell JM, Duhig T, Lamport D, White R, Parker M, TaylorPapadimitriou J. 1987. Cloning of partial cDNA encoding differentiation and tumor-associated mucin glycoproteins expressed by human mammary epithelium. Proc Natl Acad Sci USA. 84:6060-6064.
13. Gendler SJ. 2001. MUC1, the renaissance molecule. J Mammary Gland Biol Neoplasia. 6:339-353.
14. Go S, Sato C, Furuhata K, Kitajima K. 2006. Oral ingestion of mannose alters the expression level of deaminoneuraminic acid (KDN) in mouse organs. Glycoconjugate J. 23:411-421.
15. Hanisch FG, Muller S. 2000. MUC1: The polymorphic appearance of a human mucin. Glycobiology. 10:439-449.
16. Hase S. 1994. High-performance liquid chromatography of pyridylaminated saccharides. Methods Enzymol. 230:225-237.
17. Heiskanen A, Satomaa T, Tiitinen S, Laitinen A, Mannelin S, Impola U, Mikkola M, Olsson C, Miller-Podraza H, Blomqvist M, et al. 2007.NGlycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible. Stem Cells. 25:197-202.
18. Inoue S, Matsumura G. 1979. Identification of the N-glycolylneuraminyl(2→8)-N-glycolylneuraminyl group in a trout egg glycoprotein by methylation analysis and gas-liquid chromatography-mass spectrometry. Carbohydr Res. 74:361-368.
19. Inoue S, Kitajima K, Inoue Y. 1996. Identification of 2-keto-3-deoxy-D-glycero-D-galactonononic acid (KDN, deaminoneuraminic acid) residues in mammalian tissues and human lung carcinoma cells. Chemical evidence of the occurrence of KDN glycoconjugates in mammals. J Biol Chem. 271:24341-24344.
20. Inoue S, Lin S-L, Chang T, Wu S-H, Yao C-W, Chu T-Y, Troy FAII, Inoue Y. 1998. Identification of free deaminated sialic acid (2-keto-3-deoxy-D-glycero-D-galacto-nononic acid) in human red blood cells and its elevated expression in fetal cord red blood cells and ovarian cancer cells. J Biol Chem. 273:27199-27204.
21. Inoue S, Inoue Y. 2003. Ultrasensitive analysis of sialic acids and oligo/polysialic acids by fluorometric high-performance liquid chromatography. Methods Enzymol. 362:543-560.
22. Inoue S, Kitajima K. 2006. KDN (Deaminated neuraminic acid): Dreamful past and exciting future of the newest member of the sialic acid family. Glycoconjugate J. 23:277-290.
23. Inoue S, Poongodi GL, Suresh N, Chang T, Inoue Y. 2006. Identification and partial characterization of soluble and membrane bound-KDN(deaminoneuraminic acid)-glycoproteins in human ovarian teratocarcinoma PA-1, and enhanced expression of free and bound KDN in cells cultured in mannose-rich media. Glycoconjugate J. 23:401-410.
24. Irie A, Koyama S, Kozutsumi Y, Kawasaki T, Suzuki A. 1998. The molecular basis for the absence of N-glycolylneuraminic acid in humans. J Biol Chem. 273:15866-15871.
25. Iwase H, Ishii-Karakasa I, Fujii E, Hotta K, Hiki Y, Kobayashi Y. 1992. Analysis of glycoform of O-glycan from human myeloma immunoglobulin A1 by gas-phase hydrazinolysis following pyridylamination of oligosaccharides. Anal Biochem. 206:202-205.
26. Jethmalani SM, Henle KJ, Gazitt Y, Walker PD, Wang S-Y. 1997. Intracellular distribution of heat-induced stress glycoproteins. J Cell Biochem. 66:98-111.
27. Kanamori A, Kitajima K, Inoue S, Inoue Y. 1989. Isolation and characterization of deaminated neuraminic acid-rich glycoprotein (KDN-gp-OF) in the ovarian fluid of rainbow trout (Salmo gairdneri). Biochem Biophys Res Commun. 164:744-749.
28. Kean EL, Roseman S. 1966. The sialic acids X. Purification and properties of cytidine 5′-monophosphosialic acid synthetase. J Biol Chem. 241:5643-5650.
29. Kuraya N, Omichi K, Nishimura H, Iwanaga S, Hase S. 1993. Structural analysis of O-linked sugar chains in human blood clotting factor IX. J Biochem. 114:763-765.
30. Litvinov SV, Hilkens J. 1993. The epithelial sialomucin, episialin, is sialylated during recycling. J Biol Chem. 268:21364-21371.
31. Malykh YN, Schauer R, Shaw L. 2001. N-Glycolylneuraminic acid in human tumours. Biochimie. 83:623-634.
32. Martin MJ, Muotri A, Gage F, Varki A. 2005. Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med. 11:228-232.
33. Muchmore EA. 1992. Developmental sialic acid modifications in rat organs. Glycobiology. 2:337-343.
34. Nakata D, Munster A-K, Gerardy-Schahn R, Aoki N, Matsuda T, Kitajima K. 2001. Molecular cloning of a unique CMP-sialic acid synthetase that effectively utilizes both deaminoneuraminic acid (KDN) and N-acetylneuraminic acid (neu5Ac) as substrates. Glycobiology. 11:685-692.
35. Nguyen DH, Tangvoranuntakul P, Varki A. 2005. Effects of natural human antibodies against a nonhuman sialic acid that metabolically incorporates into activated and malignant immune cells. J Immunol. 175:228-236.
36. Padler-Karavani V, Yu H, Cao H, Chokhawala H, Karp F, Varki N, Chen X, Varki A. 2008. Diversity in specificity, abundance, and composition of antiNeu5Gc antibodies in normal humans: Potential implications for disease. Glycobiology. 18:818-830.
37. Royle L, Mattu TS, Hart E, Langridge JI, Merry AH, Murphy N, Harvey DJ, Dwek RA, Rudd PM. 2002. An analytical and structural database provides a strategy for sequencing O-glycans from microgram quantities of glycoproteins. Anal Biochem. 304:70-90.
38. Tangvoranuntakul P, Gagneux P, Diaz S, Bardor M, Varki N, Varki A, Muchmore E. 2003. Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid. Proc Natl Acad Sci USA. 100: 12045-12050.
39. Yin J, Hashimoto A, Izawa M, Miyazaki K, Chen G-Y, Takematsu H, Kozutsu Y, Sduzuki A, Furuhata K, Cheng F-L, et al. 2006. Hypoxic culture induces expression of sialin, a sialic acid transporter, and cancer-associated gangliosides containing non-human sialic acid on human cancer cells. Cancer Res. 66:2937-2945.
40. Zhu A, Hurst R. 2002. Anti-N-glycolylneuraminic acid antibodies identified in healthy human serum. Xenotransplantation. 9:376-381.